Coverage of efforts to overhaul drug decriminalization in Oregon cites an OHSU-PSU School of Public Health study that found a 50% gap between existing treatment resourced and what is needed statewide.

Research by Erick Turner, M.D., and Rosa Ahn-Horst, M.D., M.P.H., suggests that the sedative alprazolam, also known as Xanax XR, may be less effective than believed. Turner says: “Our study throws some cold water on the efficacy of this drug."

Research by Erick Turner, M.D., and Rosa Ahn-Horst, M.D., M.P.H., suggests that the sedative alprazolam, also known as Xanax XR, may be less effective than believed. Turner says: “Our study throws some cold water on the efficacy of this drug."

Don Sullivan, M.D., participates in a Q&A with HemOnc Today on recently published research discussing miscommunication in cancer care. Sullivan says: “Counter to what clinicians may believe, patients expect and appreciate prognosis communication being delivered in a direct but empathetic way.”

OHSU researchers recruit participants for a study on the impact of broader access to emergency contraception.

While presenting at TCT 2023, Firas Zahr, M.D., shared “high rates of device and procedural success” in the Medtronic-sponsored early feasibility study of the Intrepid transcatheter mitral valve replacement system.

Laurel Hallock-Koppelman, D.N.P., says this of the Drug Enforcement Administration’s decision to extend coverage of telehealth substance use disorder treatment: “I’m really glad they decided to extend this. They really listened to the providers. The people with their boots on the ground that are seeing patients and seeing the benefits of telehealth."

Research led by Ruth Napier, Ph.D., indicates patients with the autoimmune condition ankylosing spondylitis who have a particular mutation in the CARD9 gene may respond well to biologic treatments that inhibit the protein IL-17.

In a story from The Daily Mail, Erick Turner, M.D., discusses concerns about reported side effects from Ozempic, a drug being used widely for weight loss, saying “the evidence of a link between Ozempic and suicide is becoming more credible.”

While explaining why heart disease is more common in LGBTQIA+ people, Jennifer Huang, M.D., says: “LGBTQIA+ people often deal with different types of stress avoidance of health care and familial rejection.”